Bevacizumab in Ovarian Cancer Patients With Disease at Second-Look Surgery
Status:
Unknown status
Trial end date:
2020-11-01
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if Avastin (bevacizumab) can help to
control ovarian, fallopian, or primary peritoneal cancer that has been found during
second-look surgery.